MOTS-c Therapy in Miami
Optimize cellular energy, boost metabolic function, and support longevity with MOTS-c — a mitochondrial peptide that activates AMPK and mimics the metabolic benefits of exercise, prescribed at Rewind Anti-Aging of Miami for patients seeking peak metabolic performance.
What Is MOTS-c?
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino-acid peptide encoded by the mitochondrial genome. Discovered in 2015 by researchers at the University of Southern California, MOTS-c was the first mitochondrial-derived peptide shown to regulate metabolism at a systemic level. Unlike most peptides used in clinical practice, which are encoded by nuclear DNA, MOTS-c originates from the mitochondria — the organelles responsible for producing the energy that powers every cell in your body.
MOTS-c functions as a metabolic signaling molecule. Its primary mechanism involves activating AMPK (AMP-activated protein kinase), the enzyme often called the body's "master metabolic switch." AMPK activation triggers a cascade of metabolic effects: enhanced glucose uptake into skeletal muscle, increased fat oxidation, improved insulin sensitivity, and optimization of cellular energy production. Because these are the same pathways activated by physical exercise, MOTS-c has been classified as an "exercise mimetic" — a compound that replicates key metabolic benefits of exercise at the cellular level.
How MOTS-c Works
MOTS-c activates fundamental metabolic pathways that decline with age, restoring cellular energy production and metabolic efficiency from the mitochondrial level up.
AMPK Activation
Activates the master metabolic switch (AMPK) in skeletal muscle and other tissues, triggering enhanced glucose uptake, fat burning, and mitochondrial biogenesis — the same pathway activated by exercise.
Enhanced Fat Oxidation
Promotes the breakdown of fatty acids for energy by upregulating beta-oxidation pathways, supporting body composition improvement and reducing visceral fat accumulation.
Insulin Sensitivity
Improves glucose homeostasis by enhancing insulin signaling and increasing glucose uptake into skeletal muscle, addressing one of the core drivers of metabolic dysfunction and age-related weight gain.
Mitochondrial Biogenesis
Stimulates the creation of new mitochondria and optimizes existing mitochondrial function, increasing cellular energy production capacity — a critical factor in combating age-related fatigue and decline.
Longevity Signaling
Research suggests MOTS-c levels decline with age and correlate with metabolic health status. Restoring MOTS-c levels may support healthy aging by maintaining the metabolic resilience characteristic of younger physiology.
Who Is MOTS-c For?
MOTS-c therapy is designed for individuals looking to optimize metabolic function, enhance exercise performance, and support cellular health as part of a longevity-focused protocol.
Age-Related Metabolic Decline
Adults over 40 experiencing slower metabolism, increased body fat, declining energy levels, or difficulty maintaining body composition despite consistent effort.
Exercise Optimization
Active individuals and athletes who want to enhance the metabolic benefits of their training, improve exercise capacity, and support recovery through mitochondrial optimization.
Insulin Resistance
Patients with early metabolic syndrome, prediabetes, or insulin resistance who want to improve glucose metabolism and insulin sensitivity alongside lifestyle interventions.
Longevity Protocols
Health-conscious individuals interested in proactive longevity strategies that target the mitochondrial decline underlying many aspects of biological aging.
What to Expect with MOTS-c
MOTS-c is administered via subcutaneous injection, typically 3 to 5 times per week. The peptide is injected using a small insulin-type syringe into the subcutaneous fat layer of the abdomen or thigh. Most patients find the injection process quick, simple, and virtually painless after the first few administrations.
Treatment protocols typically run 8 to 12 weeks. Many patients report improvements in energy levels, exercise tolerance, and overall metabolic function within the first 2 to 4 weeks. Body composition changes — reduced body fat percentage, improved muscle-to-fat ratio — typically become measurable by weeks 4 to 8. Because MOTS-c works at the mitochondrial level, its benefits tend to compound over time as mitochondrial function and density improve.
At Rewind Anti-Aging of Miami, MOTS-c is often prescribed as part of a comprehensive longevity or metabolic optimization protocol. Your provider may recommend combining it with other therapies such as NAD+ therapy or sermorelin depending on your individual goals and metabolic assessment.
Weeks 1-2: Initiation
Begin subcutaneous injections per protocol. Some patients notice subtle energy improvements early. Metabolic pathways begin activating at the cellular level.
Weeks 2-4: Early Response
Increased energy, improved exercise tolerance, and enhanced recovery commonly reported. AMPK activation and mitochondrial optimization measurably underway.
Weeks 4-12: Full Benefits
Measurable improvements in body composition, insulin sensitivity, and metabolic markers. Compounding benefits of mitochondrial biogenesis become apparent. Protocol refinement based on progress.
Side Effects of MOTS-c
MOTS-c has a favorable safety profile. Side effects are generally mild and uncommon, making it one of the better-tolerated peptides in clinical use.
Injection site reactions
Mild redness, swelling, or tenderness at the injection site. This is the most commonly reported side effect and typically resolves within hours.
Transient flushing
Some patients experience brief warmth or flushing after injection. This is usually mild and passes quickly without intervention.
Mild headache
Rarely reported and typically limited to early treatment. Adequate hydration and consistent dosing timing can help minimize this effect.
As with all peptide therapies, MOTS-c should be used under medical supervision. Your provider monitors your response and adjusts the protocol as needed throughout treatment.
Related Treatments
Sermorelin Therapy
Growth hormone-releasing peptide that stimulates natural HGH production for anti-aging, body composition, and recovery.
Learn more →Tesamorelin Therapy
FDA-approved GHRH analog that targets visceral fat reduction and supports metabolic health.
Learn more →NAD+ Therapy
Cellular energy restoration with NAD+ to support mitochondrial function, DNA repair, and healthy aging.
Learn more →Explore MOTS-c and Peptide Therapy
Frequently Asked Questions About MOTS-c
What is MOTS-c and where does it come from?
MOTS-c is a mitochondrial-derived peptide consisting of 16 amino acids. It is encoded by the mitochondrial DNA (mtDNA) — specifically the 12S rRNA gene — making it one of the few known peptides produced by mitochondria rather than nuclear DNA. MOTS-c was first identified by researchers at the University of Southern California in 2015 and has since been recognized as a key regulator of metabolic homeostasis, exercise adaptation, and cellular energy production.
How does MOTS-c support metabolism?
MOTS-c activates AMPK (AMP-activated protein kinase), which is the master metabolic switch in your cells. When AMPK is activated, it promotes glucose uptake into skeletal muscle, enhances fat oxidation, improves insulin sensitivity, and shifts cellular metabolism toward energy production. MOTS-c essentially mimics many of the metabolic benefits of exercise at the cellular level, which is why it is sometimes called an exercise mimetic.
Is MOTS-c the same as exercising?
MOTS-c activates many of the same cellular pathways that exercise activates — particularly AMPK signaling and metabolic adaptation. However, it is not a replacement for physical activity. Exercise provides cardiovascular conditioning, musculoskeletal loading, neurological benefits, and psychological effects that no peptide can replicate. MOTS-c is best understood as a metabolic enhancer that amplifies the benefits of exercise and supports metabolic function, especially in patients with reduced exercise capacity or age-related metabolic decline.
Who is a good candidate for MOTS-c therapy?
MOTS-c is well suited for adults experiencing age-related metabolic decline, insulin resistance, reduced exercise tolerance, fatigue, or those interested in longevity-focused protocols. It is also used by patients looking to optimize body composition and cellular energy production. Because MOTS-c levels naturally decline with age, supplementation may be particularly beneficial for individuals over 40 who want to support mitochondrial function and metabolic health.
What are the side effects of MOTS-c?
MOTS-c has a favorable safety profile in clinical use. The most commonly reported side effects are mild injection site reactions (redness, slight soreness) and occasional transient flushing. Serious adverse effects have not been documented at therapeutic doses. As with all peptide therapies, MOTS-c should be used under medical supervision with proper dosing and monitoring.
How is MOTS-c administered?
MOTS-c is administered via subcutaneous injection, typically 3 to 5 times per week depending on the protocol. Injections are given using a small insulin-type syringe into the subcutaneous fat layer of the abdomen or thigh. Treatment cycles typically run 8 to 12 weeks, and your provider at Rewind Anti-Aging of Miami will design a protocol based on your individual health goals and metabolic status.
Optimize Your Metabolism with MOTS-c
Whether you are focused on metabolic health, exercise performance, or longevity, MOTS-c therapy may be the right fit for your goals. Schedule a consultation to learn more.
References
- Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454.
- Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470.
- Kim SJ, Mehta HH, Wan J, et al. Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging (Albany NY). 2018;10(6):1239-1256.
⚕ Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. All treatments at Rewind Anti-Aging of Miami are performed under the supervision of licensed medical professionals. Individual results may vary. Consult your physician before beginning any new treatment protocol.
Meet our clinical team →Areas We Serve in Miami & South Florida
Our Wynwood clinic at 24 NW 29th Street serves patients across the Miami metro in person and the entire state of Florida via telehealth.